BSE
Your Result on : Company News
Caplin Point Laboratories Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524742
ISIN Demat
INE475E01026
Book Value (Rs)
269.7614245
NSE Symbol
CAPLIPOINT
Divident Yield %
0.17
Market Cap
(Rs In Cr.)
17,967
P/E (TTM)
45.31
EPS (TTM)
52.17
Face Value
(Rs)
2
Date Heading
10-Jun-26 Caplin Point Lab jumps over 20% in five days
15-May-26 Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
14-May-26 Board of Caplin Point Laboratories recommends interim dividend
14-May-26 Caplin Point Laboratories consolidated net profit rises 19.32% in the
08-May-26 Caplin Point Laboratories to convene board meeting
06-May-26 Caplin Point gains as arm gets USFDA nod for Calcium Gluconate Injecti
28-Feb-26 Caplin receives USFDA approval for Desmopressin Acetate Injection
24-Feb-26 Caplin Point’s arm Caplin Steriles gets USFDA nod for Sodium Phosphate
05-Feb-26 Caplin Point Laboratories consolidated net profit rises 17.93% in the
27-Jan-26 Caplin Point Laboratories to announce Quarterly Result
30-Dec-25 Volumes spurt at Honasa Consumer Ltd counter
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)